Page last updated: 2024-08-25

3-deazaneplanocin and Adenocarcinoma

3-deazaneplanocin has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Behrens, C; Coombes, KR; Girard, L; Heymach, J; Hong, WK; Lee, JJ; Lin, HY; Minna, JD; Nilsson, MB; Riquelme, E; Simon, G; Suraokar, M; Wang, J; Wistuba, II	1

Other Studies

1 other study(ies) available for 3-deazaneplanocin and Adenocarcinoma

Article	Year
VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jul-15, Volume: 20, Issue:14 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine; Animals; Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Mice, Nude; MicroRNAs; Molecular Targeted Therapy; Polycomb Repressive Complex 2; Signal Transduction; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays	2014

Article

Year

VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jul-15, Volume: 20, Issue:14

Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine; Animals; Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Mice, Nude; MicroRNAs; Molecular Targeted Therapy; Polycomb Repressive Complex 2; Signal Transduction; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2014